In The News Posted February 28, 2019 Share Posted February 28, 2019 SILVER SPRING, Md., Feb. 28, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration posted a warning letter to CanaRx for facilitating the distribution of unapproved new drugs and misbranded drugs to U.S. consumers. These drugs are potentially dangerous to U.S. consumers. "The... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.